GEP20156216B - Heterocyclic compound and usage thereof - Google Patents

Heterocyclic compound and usage thereof

Info

Publication number
GEP20156216B
GEP20156216B GEAP201113021A GEAP2011013021A GEP20156216B GE P20156216 B GEP20156216 B GE P20156216B GE AP201113021 A GEAP201113021 A GE AP201113021A GE AP2011013021 A GEAP2011013021 A GE AP2011013021A GE P20156216 B GEP20156216 B GE P20156216B
Authority
GE
Georgia
Prior art keywords
usage
heterocyclic compound
амра
isoxasole
schizophrenia
Prior art date
Application number
GEAP201113021A
Other languages
English (en)
Inventor
Michiyo Mochizuki
Osamu Ujikawa
Yasutomi Asano
Eiji Honda
Masashi Toyofuku
Shinji Nakamura
Toshihiro Imaeda
Masakuni Kori
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of GEP20156216B publication Critical patent/GEP20156216B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GEAP201113021A 2010-08-10 2011-08-09 Heterocyclic compound and usage thereof GEP20156216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
GEP20156216B true GEP20156216B (en) 2015-01-12

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201113021A GEP20156216B (en) 2010-08-10 2011-08-09 Heterocyclic compound and usage thereof

Country Status (39)

Country Link
US (11) US9150591B2 (https=)
EP (1) EP2603513B1 (https=)
JP (2) JP5788496B2 (https=)
KR (1) KR101852215B1 (https=)
CN (2) CN104926837A (https=)
AR (1) AR082618A1 (https=)
AU (1) AU2011290126B2 (https=)
BR (1) BR112013002250B1 (https=)
CA (1) CA2807460C (https=)
CL (1) CL2013000380A1 (https=)
CO (1) CO6680700A2 (https=)
CR (1) CR20130066A (https=)
CY (1) CY1123507T1 (https=)
DK (1) DK2603513T3 (https=)
DO (1) DOP2013000030A (https=)
EA (1) EA022078B1 (https=)
EC (1) ECSP13012478A (https=)
ES (1) ES2793723T3 (https=)
GE (1) GEP20156216B (https=)
HR (1) HRP20200844T1 (https=)
HU (1) HUE049460T2 (https=)
IL (1) IL224452A (https=)
LT (1) LT2603513T (https=)
MA (1) MA34509B1 (https=)
MX (1) MX349470B (https=)
MY (1) MY165908A (https=)
NZ (1) NZ607593A (https=)
PE (1) PE20131116A1 (https=)
PH (1) PH12013500247A1 (https=)
PL (1) PL2603513T3 (https=)
PT (1) PT2603513T (https=)
RS (1) RS60311B1 (https=)
SG (1) SG187656A1 (https=)
SI (1) SI2603513T1 (https=)
TW (1) TWI504604B (https=)
UA (1) UA111594C2 (https=)
UY (1) UY33551A (https=)
WO (1) WO2012020848A1 (https=)
ZA (1) ZA201301120B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150591B2 (en) * 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
EP2694472B1 (en) 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
US20150011554A1 (en) * 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
DK3013813T3 (da) 2013-06-27 2019-06-03 Pfizer Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
MX2016007259A (es) 2013-12-03 2016-08-04 Du Pont Pirrolidinonas como herbicidas.
US9944602B2 (en) 2014-07-02 2018-04-17 E. I. Du Pont De Nemours And Company Piperidinone herbicides
EP3230264B1 (en) 2014-12-08 2019-09-11 FMC Corporation 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
EP3280709B1 (en) 2015-04-10 2021-05-26 FMC Corporation Substituted cyclic amides as herbicides
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
MX373652B (es) * 2015-04-29 2020-04-02 Janssen Pharmaceutica Nv Imidazopirazinas y pirazolopirimidinas y su uso como moduladores del receptor de ampa.
ES2865330T3 (es) 2015-04-29 2021-10-15 Janssen Pharmaceutica Nv Azabenzimidazoles y su uso como moduladores del receptor AMPA
PL3294743T3 (pl) 2015-05-12 2020-03-31 Fmc Corporation Podstawione arylem związki bicykliczne jako środki chwastobójcze
WO2016196019A1 (en) 2015-05-29 2016-12-08 E I Du Pont De Nemours And Company Substituted cyclic amides as herbicides
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
CN108137512B (zh) 2015-07-31 2022-05-31 Fmc公司 用作除草剂的环状n-酰胺化合物
KR102579520B1 (ko) * 2015-08-06 2023-09-15 에프. 호프만-라 로슈 아게 Galnac 산 유도체의 제조 방법
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
CA3047724A1 (en) 2016-12-21 2018-06-28 Fmc Corporation Nitrone herbicides
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
WO2018175231A1 (en) 2017-03-21 2018-09-27 Fmc Corporation Herbicidal mixture, composition and method
CA3057297A1 (en) 2017-03-21 2018-09-27 Fmc Corporation Pyrrolidinones and a process to prepare them
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
US11407748B2 (en) 2017-10-06 2022-08-09 Takeda Pharmaceutical Company Limited Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
ES2971497T3 (es) 2017-10-06 2024-06-05 Takeda Pharmaceuticals Co Compuestos heterocíclicos
CR20220160A (es) 2019-09-16 2022-06-16 Takeda Pharmaceuticals Co Derivados de piridazin-3(2h)-ona fusionados con azol
TW202207944A (zh) * 2020-05-15 2022-03-01 日商武田藥品工業股份有限公司 抑鬱症之治療
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders
WO2026050231A1 (en) 2024-08-27 2026-03-05 Neurocrine Biosciences, Inc. Method of treating a bipolar disorder

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (https=) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
JP2003526341A (ja) 1999-11-04 2003-09-09 コロラド ステート ユニバーシティー リサーチ ファウンデーション 昆虫を誘引するための装置および方法
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA04003297A (es) 2001-10-10 2004-07-23 Neurosearch As Derivados novedosos de benzotiacina su preparacion y uso.
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007262661A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
WO2008073789A1 (en) * 2006-12-11 2008-06-19 Eli Lilly And Company Ampa receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
MX2010005028A (es) 2007-11-05 2010-05-27 Schering Corp Moduladores de gamma secretasa.
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009119088A1 (ja) 2008-03-25 2009-10-01 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
AU2009313527A1 (en) 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
WO2011007756A1 (ja) 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
US9150591B2 (en) * 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Also Published As

Publication number Publication date
MY165908A (en) 2018-05-18
HUE049460T2 (hu) 2020-09-28
LT2603513T (lt) 2020-05-25
AU2011290126A1 (en) 2013-03-07
CO6680700A2 (es) 2013-05-31
BR112013002250B1 (pt) 2020-10-27
EA022078B1 (ru) 2015-10-30
CN104926837A (zh) 2015-09-23
US20180162875A1 (en) 2018-06-14
US20130190291A1 (en) 2013-07-25
US20150073137A1 (en) 2015-03-12
DK2603513T3 (da) 2020-06-15
CN103180326A (zh) 2013-06-26
CL2013000380A1 (es) 2013-05-31
JP2013535408A (ja) 2013-09-12
US8916551B2 (en) 2014-12-23
CR20130066A (es) 2013-05-03
US20190263832A1 (en) 2019-08-29
NZ607593A (en) 2015-01-30
EA201390222A1 (ru) 2013-08-30
WO2012020848A8 (en) 2012-09-27
EP2603513A1 (en) 2013-06-19
TWI504604B (zh) 2015-10-21
US8575154B2 (en) 2013-11-05
MX2013001614A (es) 2013-07-05
CA2807460A1 (en) 2012-02-16
UY33551A (es) 2012-03-30
AR082618A1 (es) 2012-12-19
DOP2013000030A (es) 2013-03-15
MA34509B1 (fr) 2013-09-02
US20150353578A1 (en) 2015-12-10
JP6113789B2 (ja) 2017-04-12
US9150591B2 (en) 2015-10-06
US9884875B2 (en) 2018-02-06
US9499568B2 (en) 2016-11-22
US20240360156A1 (en) 2024-10-31
BR112013002250A2 (pt) 2016-05-24
TW201217386A (en) 2012-05-01
AU2011290126B2 (en) 2016-01-07
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
SG187656A1 (en) 2013-03-28
CN103180326B (zh) 2015-06-10
PE20131116A1 (es) 2013-10-24
JP2016006080A (ja) 2016-01-14
US20120077799A1 (en) 2012-03-29
US20200317692A1 (en) 2020-10-08
MX349470B (es) 2017-07-31
CY1123507T1 (el) 2022-03-24
WO2012020848A1 (en) 2012-02-16
ZA201301120B (en) 2014-04-30
US10654874B2 (en) 2020-05-19
US11279713B2 (en) 2022-03-22
CA2807460C (en) 2018-09-18
ES2793723T3 (es) 2020-11-16
US20130184266A1 (en) 2013-07-18
US20140080817A1 (en) 2014-03-20
PT2603513T (pt) 2020-06-08
US8778934B2 (en) 2014-07-15
PH12013500247A1 (en) 2013-03-11
ECSP13012478A (es) 2013-04-30
IL224452A (en) 2017-11-30
PL2603513T3 (pl) 2020-07-27
EP2603513B1 (en) 2020-03-11
US20170022222A1 (en) 2017-01-26
RS60311B1 (sr) 2020-07-31
HRP20200844T1 (hr) 2020-08-21
KR101852215B1 (ko) 2018-04-25
KR20130138738A (ko) 2013-12-19
JP5788496B2 (ja) 2015-09-30

Similar Documents

Publication Publication Date Title
GEP20156216B (en) Heterocyclic compound and usage thereof
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
NZ593004A (en) Azaazulene compounds
HUE039731T2 (hu) l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
MX2007011023A (es) 2-(4-oxo-4h-quinazolin-3-il) acetamidas y su uso como antagonistas de vasopresin v3.
EA019970B8 (ru) Производные имидазолидиндиона
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
GEP20146072B (en) New compounds
GEP20146125B (en) Aminopyrimidines as syk inhibitors
GEP20146124B (en) Novel ccr2 receptor antagonists and usage thereof
MY155517A (en) Heterocyclic derivatives
NZ601121A (en) 5-alkynyl-pyrimidines
GEP20166554B (en) Nitrogenated heterocyclic compound
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
TN2011000368A1 (en) Fused ring compound and use thereof
WO2008113559A3 (en) Indolizines and aza-analog derivatives thereof as cns active compounds
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
GEP20146099B (en) Fused imidazole carboxamides as trpv3 modulators
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
TW200738651A (en) Cyclohexyl sulfonamide derivatives
EP2578587A4 (en) PYRAZOLE DERIVATIVES
UA104867C2 (uk) Похідні феноксихроманкарбонової кислоти, заміщені в 6-ому положенні
MX2013008699A (es) Compuestos para reducir la produccion de beta-amiloide.